In a major development that has the mental health community buzzing—literally—a US clinical trial has found that stimulating the vagus nerve with a small electrical pulse reduces severe depression symptoms by an astonishing 70%. The device, worn like a futuristic choker, sends tiny jolts to the brain's longest highway, rewiring emotional traffic patterns. Participants reported feeling 'a strange fluttering,' followed by 'a distinct absence of despair.' But let's pause here. If a $500 gizmo can reboot a brain as easily as a modem, what happens to the data? The device logs every mood spike, every dosage adjustment, and every moment you were too apathetic to charge it. Who owns that? Trials are already showing that patients who skip two sessions are flagged as 'non-compliant,' and early whispers suggest insurance companies are salivating over these behavioral logs. Imagine a future where your negotiable premium is based on how often you let your neck-bone buzz. The consequence is a tangled web of corporate hijinks. Tech giants are jumping in, because a depressed person's biometric data is a goldmine for every wellness app, supplement company, and sleep-tracker brand. We're not just curing depression; we're creating a subscription model for happiness. 'Your VNS score is low today—would you like to upgrade to the Platinum Zest Package?' The finale? A world where your most intimate neural patterns are sliced and diced by a data broker. It's a miracle cure that asks a question so obvious it may give you a headache: 'If this works, why does it feel like you're just swapping one kind of tether for another?'